MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Itamar Set to Acquire Technology and Assets of Spry Health

pichetw-stock.adobe.com Jan.jpg
Spry Health has developed the Loop System, a wrist-based medical-grade remote patient monitoring (RPM) solution.

Itamar Medical has entered into an agreement to acquire the technology and assets of Spry Health for an undisclosed cash amount. Spry, based in the San Francisco Bay area, develops a wrist-based medical grade remote patient monitoring (RPM) solutions.

Spry winner of the 2018 MedTech Startup Showdown has FDA clearance for its Loop System. The device is based on an extensive set of sensing technologies and algorithms that contextualize real-time, continuous physiologic data to flag signs of patient deterioration using bio-markers such as SpO2, respiration rate, and heart rate.

These three signals, combined with Itamar’s core expertise in the Peripheral Arterial Tonometry, form the foundation for continuous sleep apnea monitoring. Itamar anticipates commencing the development of a new wrist-worn device immediately, with initial market launch timing anticipated in 2022.

“As we sought opportunities to build on our vision of expanding sleep apnea diagnostics from a single-night test to continuous remote patient monitoring, we identified the technology commercialized by Spry Health as a perfect fit,” said Gilad Glick, president and CEO of Itamar Medical. “The acquisition of their FDA-cleared, wrist-worn technology and the addition of a knowledgeable pool of selected talented engineers, led by Spry co-founder and CTO Elad Ferber, provides an excellent platform for us to jump-start our development initiatives to bring to market a continuous sleep apnea monitoring device to further support chronic disease management, particularly as it contributes to the added burden on cardiovascular disease.”

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish